Fact CheckerSign in

NCT06714812Active, not recruiting

Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib

Characteristics of Diarrheal Adverse Events in a Caucasian Population of Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib - Pilot Study

Source: ClinicalTrials.gov · Last updated 19 Dec 2025

Brief summary (registry, in English)

The goal of this observational study is to identify the demographic and clinical characteristics associated with the development of diarrheal adverse events in a Caucasian population with IPF undergoing treatment with nintedanib. Additionally this study aims to evaluate the different therapeutic strategies for dose reduction of nintedanib and assess the effectiveness of these strategies in reducing the occurrence of diarrhea.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (actual)
First submitted
28 Nov 2024
Start date
20 Aug 2023
Primary completion date
31 Dec 2023
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT number
NCT06714812

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 20 Aug 2023 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • clinical and functional data not availbale

Who the study is looking for

  • Caucasian ethnicity;
  • Age ≥ 18 years;
  • Subjects with a diagnosis of IPF who started antifibrotic therapy with nintedanib on or after 01/06/2020.
  • Obtaining written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Azienda Ospedaliera-Universitaria di Bologna
Coordinator of this site? Confirm its status
BolognaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.